Author

G. Schor

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

B. Ma· 2 shared C. G. Lee· 2 shared J. A. Elias· 2 shared S. Kamle· 2 shared B. Pham· 1 shared C. Azzoli· 1 shared C. M. Lee· 1 shared C.-M. Lee· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

B. Ma

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Chitinase 3-like-1 (CHI3L1) in the Pathogenesis of Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer

S. Kamle, B. Ma, G. Schor, M. Bailey, B. Pham, I. Cho, H. Khan, C. Azzoli, M. Hofstetter, C.-M. Lee, R. Herbst, K. Politi, C. G. Lee, J. A. Elias

This study shows CHI3L1 is induced by EGFR activation in NSCLC and promotes EGFR signaling, with anti-CHI3L1 antibodies reversing TKI resistance and inhibiting metastasis.

bioRxiv · Sep 21, 2023Cancer Biology

Host Chitinase 3-like-1 is a Universal Therapeutic Target for SARS-CoV-2 Viral Variants in COVID 19

S. Kamle, B. Ma, C. M. Lee, G. Schor, Y. Zhou, C. G. Lee, J. A. Elias

This study shows that targeting CHI3L1 inhibits SARS-CoV-2 variants' infection of epithelial cells, suggesting it as a universal therapeutic target.

bioRxiv · Jan 21, 2022Immunology